Core Insights - Beijing Xinyang Technology Co., Ltd. has launched the Youth Selection Alliance with 14 upstream manufacturers to achieve mutual benefits through collaboration in pricing, supply, training, and product traceability [1] - Xinyang has partnered with Sota China to ensure independent traceability for each Thermage treatment head, offering a "tenfold compensation" guarantee for non-compliant equipment [1] - The Chinese medical aesthetics market has reached a scale of over 100 billion yuan, growing at a compound annual growth rate of 22.6%, but faces challenges such as high costs and inconsistent service quality [1] Company Developments - Since 2021, Xinyang has invested 1 billion yuan to build a supply chain system, establishing 9 medical device sales companies and a network of warehouses to enhance product supply and ensure safety and transparency [2] - Xinyang's Youth Clinics have opened 50 stores across 16 cities, aiming to be the leading light medical aesthetics chain by September 2025, with a target of 1 million treatments completed by January 2026 [2] - The CEO of Xinyang emphasizes a focus on user experience, standardized medical delivery, a robust supply chain, and digital operations to enhance service transparency [2] Future Goals - Xinyang aims for quarterly profitability by 2026 while continuing to invest in its infrastructure and improving gross margins through a diverse product offering [3] - The company plans to adhere to a "conservative selection" principle for new products in the fields of light therapy, water injection, and health, with a goal to open 35 new stores and increase the number of doctors to 500 and nursing staff to 1,000 by the end of 2026 [3]